Tech Company Financing Transactions
Somite Therapeutics Funding Round
On 5/13/2025, Somite Therapeutics announced Series A funding from Khosla Ventures, Ajinomoto Co and Chan Zuckerberg Initiative.
Transaction Overview
Company Name
Announced On
5/13/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate key therapeutic programs, including beta cells for type 1 diabetes, articular cartilage for orthopedic applications, satellite cells for muscular diseases, and hematopoietic cells for blood disorders, and further develop the capabilities of its DeltaStem platform.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
240 Longwood Ave, Building C
Boston, MA 02115
USA
Boston, MA 02115
USA
Phone
Undisclosed
Website
Email Address
Overview
Somite.ai is leveraging big data and AI to introduce novel cell replacement therapies. We're developing a digital twin of the embryo, i.e. a computational model that simulates the real embryo's development and behavior to guide decision-making.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Micha Breakstone
Chief Scientific Officer
Carl Morris
Chief Technical Officer
Jonathan Rosenfeld
Co-Founder
Allon Klein
Co-Founder
Olivier Pourquie
Co-Founder
Cliff Tabin
VP - Bus. Development
Kristy Brown
Browse more venture capital transactions:
Prev: 5/13/2025: Scription venture capital transaction
Next: 5/13/2025: Cart.com venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs